Clinical Trial Detail

NCT ID NCT02101905
Title Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

glioblastoma multiforme

astrocytoma

oligodendroglioma

mixed glioma

malignant ependymoma

malignant glioma

gliosarcoma

Therapies

Lapatinib

Age Groups: adult senior

No variant requirements are available.